CMS has issued a preliminary decision to establish a product specific Healthcare Common Procedure Coding System J code for Photrexa drug formulations, according to a press release from Avedro.
Photrexa formulations are the only drugs approved by the FDA for use with the KXL System in corneal cross-linking, and if finalized, a J code will simplify billing for the procedure, the release said.
“A product specific J code will streamline the claims submission process for physician practices and better serve ectatic patients in need of treatment,” OSN Cornea/External Disease Board Member
Uncategorized